Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Paragon Bioservices Makes Leadership Promotions | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Paragon Bioservices Makes Leadership Promotions

Both Deborah Wild and Ruby Hofmann appointed to SVP roles

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Paragon Bioservices has made two key leadership promotions. Deborah Wild has been promoted from vice president, quality, validation and regulatory affairs to senior vice president, quality, validation and regulatory affairs. Ruby Hofmann has been promoted from vice president, human resources and organizational development to senior vice president, human resources and organizational development.

“As Paragon Bioservices continues its track record of rapid growth, we’re strengthening our leadership ranks with the promotions of Deborah Wild and Ruby Hofmann. These promotions reflect each of their contributions to Paragon: they are exceptional leaders who have been instrumental in the current success of Paragon and will play important roles in driving future successes,” said Pete Buzy, president and chief executive officer, Paragon Bioservices. “Deb has led the charge in defining our quality philosophy and has been a key driver in the BWI expansion project. Ruby has revamped our HR function by formalizing the talent acquisition team and evolving our corporate culture.”

Ms. Wild is an accomplished quality executive with more than 30 years of experience. Most recently, she ran a consulting practice where she led quality assurance-focused initiatives for high-profile clients such as Genentech, TEVA, Polynoma, Cytovance and CMC Biologics.

Ms. Hofmann is a human resource business leader with more than 25 years of demonstrated success in creating business-driven HR strategies. At Paragon, Ms. Hofmann develops HR-focused, results-oriented solutions that are advancing organizational performance, creating a stronger workforce, while developing exceptional leadership.

Earlier this year, Paragon Bioservices announced its plans for expansion, including late-phase and commercial manufacturing-acquiring a new 150,000-square-foot process development and cGMP manufacturing facility outside of Baltimore, MD.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters